To offset the rumors that I have magically conjured up the answers to our behaviors through some special relationship with Nature that I alone seem to possess, I have painstakingly provided a sample of the references utilized in composition of The Theorem: A Complete Answer to Human Behavior. Of course they were always there, published since the very first edition on pages 475 to 496. No matter, my critics are a lazy, morbid bunch; too intellectually impoverished to purchase a book and look for themselves. They want you to believe that the discovery is so impossible that they will stop at nothing to mislead the potential reader and prevent you from opening up the book; seeing for yourself what many others have already seen. This of course is that no one does it alone.
Whatever you accomplish of value, it is a hard road. This is especially true when you seek to create something significant in a seemingly insignificant society. As easy as this discovery seems to roll off my pen, I can guarantee that this was not the case. Instead, the supposed ease at which each of these disorders and behaviors are portrayed in a seamless fit, is a result of over 30,000 mind-numbing hours of work personally accomplished. It was during these many long hours that the names on the following pages took on a life of their own. So began a one sided friendship. Overwrought from a lack of sleep, absence of external stimulus and locked in a reality that I perhaps never want to return to; I would vocalize my admiration or dissatisfaction at the direction of research each of these studies represented. In other words, debating with a piece of paper for all practical purposes. I would say out loud, “No researcher so and so, you are going the wrong way”. Or, “Yes researcher you are on the right track here!” I know this is a strange confession, one my previous publisher would probably not recommended me making, but it was indeed an integral part of the discovery process nonetheless. A process that itself has no set of established guidelines or criteria, with the exception of forever changing the life of the individual it consumes.
Have no concern if your name does not appear on these references. Why? Well because I was only able to publish a small sample, one chapter’s worth, of the 2308 references actually utilized in the development of The Theorem’s behavioral model. This was of course due to space limitations of being a first time author (It was hard even to be allowed 500 pages). I am hopeful however of the future. I see a day ahead when The Theorem’s acceptance is universal and I will have some real pull with my future publisher. It will be on that day that the entire list can be published. True it may take a small forest to add those extra hundred plus pages to book, but I am in the heartfelt belief that it will be worth it. Until that day comes however, this will have to suffice.
I do want to take this opportunity to once again thank all of the hundreds of thousands of hours that the names on this list represent; the women and men, and their work accomplished. I certainly could not have done it without your dedication to your respective discipline.
Douglas M. Arone
1. Vecchietti G & Borruro F, Echotomographic evaluation of embryo-fetal movements, Ann Oster Ginecol Med Perinat, 102(6): 398-400, 1981.
2. Hopson JL, Fetal psychology, Psychology Today, 31(5): 44, 1998.
3. De Vries JP & Prechtl HFR, The emergence of fetal behavior, Early Human Dev, 7: 301-322, 1982.
4. Van Dongen LGR & Goudie EG, Fetal movements in the first trimester of Pregnncy, British J of Obstet and Gynec, 87: 191-193, 1980.
5. DiPietro JA, Hodgson DM, Costigan KA, Hilton SC & Johnson TR, Development of fetal movement - feral heart rate coupling from 20 weeks through term, Early Hum Dev, 44(2): 139-51, 1996.
6. DiPierro JA, Hodgson DM, Costigan KA, Hilton SC & Johnson TRB, Development of feral movement and feral heart rate coupling from 20 weeks through term, Early Hum Dev, 44: 139-151, 1996.
7. ArmonyJL, Cohen JD, Servan-Schreiber D & LeDoux JE, An anatomically constrained neural network model of fear conditioning, Behav Neurosci, 109(2):246-257, 1995.
8. Peleg D, Munsick RA, Diker D, Goldman JA & Ben-Jonathan N, Distribution of catecholamines between feral and maternal compartments during human pregnancy with emphasis on L-dopa and dopamine, J Clin Endocrinology &Metabolism, 62:911-914, 1986.
9. Stark H, Rothe T, Wagner T & Scheich H, Learning a new behavioral strategy in the shuttle-box increases prefrontal dopamine, Neurosci, 126: 21-29, 2004.
I 0. Seron-Ferre M, Ducsay CA, Valenzuela GJ, Circadian rhythms during pregnancy, Endocrine Reviews 14(5): 594-609, 1993. 11. de Vries JP, Visser GHA & Prechtl HFR, The emergence of fetal behavior: Individual differences and consistencies, EH Develop, 16(1) 95-102, 1988.
12. Health Guide, Prolactin, www.WebMDHealth.com, 2004.
13. Hernandez ML, Fernandez-Ruiz JJ, Navarro M, De Miguel R, Cebeira M, Vatican L & Ramos JA, Modifications of mesolimbic and nigrostriatal dopaminergic activities after intracerebroventricular administration of prolactin, JNeural Transm, 96: 63-79, 1994.
14. Brown RE, An introduction to neuroendocrinology, Cambridge University Press, 1994.
15. Worth J, Onyeije CI, Ferber A, Pondo JS & Divan MY, The association between fetal and maternal sleep patterns in third-trimester pregnancies, Am J Obstet Gynecol, 186(5): 924-925, 2002.
16. Backing A, Adamson L, Cousin A, Campbell K, Carmichael L, Natale R & Patrick J, Effects of intravenous glucose injections on human fetal breathing movements and gross fetal body movements at 38 to 40 weeks' gestational age, Am J Obster Gynecol, 142(6 Pt 1): 606-611, 1982.
17. Patrick J, Campbell K, Carmichael L, Natale R & Richardson B, Patterns of human fetal breathing during the last 10 weeks of pregnancy, Obstet Gynecol,56(1): 24-30, 1980.
18. Power M, How the body renews itself hour by hour, Pretoria News, August 11, 2004.
19. Burghardt NS, Sullivan GM, McEwen BS, Gorman JM & LeDoux JB, The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: a comparison with tianeptine, Bioi Psychiatry, 55: 1171-1178, 2004.
20. Phelps EA, Human emotion and memory: interactions of the amygdale and hippocampal complex, Current Opinion in Neurobiology, 14: 198-202, 2004.
21. McDonald AJ & Mascagni F, Cortico-cortical and cortico-amygdaloid projections of the rat occipital cortex: a phaseolus vulgaris leucoagglutinin study, Neurosci, 71(1): 37-54, 1996.
22. Carter R.,l\l', Pinnock B & Herbert J, Does the amygdale modulate adaptation to repeated stress? Neurosci, 126: 9-19, 2004.
23. Paradiso S, Johnson DL, Andreasen NC, O'Leary DS, Watkins GL & Ponto LL, Cerebral blood How changes associated with attribution of emotional valence w pleasant, unpleasant, and neutral visual stimuli in a PET study of normal Subjects. Am J Psychiatry, 156: 1618-1629, 1999.
24. Beck CH & Fibiger HC, Conditioned fear-induced changes in behavior and in the expression of the immediate earle gene c-fos; with and without diazepam pretreatment, J Neurosci, 15: 709-720, 1995.
25. Calder AJ, Lawrence AD & Young AW, Neuropsychology of fear and loathing, Nature Reviews Neuroscience, 2: 352-363, 2001.
26. Yamamoto T, Azuma S & Kawamura Y, Functional relations between the cortical gustatory area and the amygdala: electrophysiological and behavioral studies in rats, Exp Brain Res, 56(1): 23-31, 1984.
27. Edited by Bauman ML & Kemper TL, The neurobiology of autism, John Hopkins University Press, 1994.
28. Stalnaker TA & Berridge CW, AMPA receptor stimulation within the central nucleus of the amygdale elicits a differential activation of central dopaminergic systems, Neuropsychopharmacology, 28: 1923-1934, 2003.
29. Everitt BJ, Cador M & Robbins TW, Interactions between the amygdale and ventral striatum in stimulus-reward associations: studies using a second-order schedule of sexual reinforcement, Neurosci, 30: 63-75, 1989.
30. Davis M & Whalen PJ, The amygdala: vigilance and emotion, Mol Psychiatry, 6: 13-34, 2001.
31. Cahill I, Haier RJ, White NS, Fallon J, Kilpatrick L, Lawrence C, Parkin SG & Alkire MT, Sex-related difference in amygdala activity during emotionally influenced memory storage, Neurobiol Learn Mem, 75: 1-9, 2001.
32. Canli T, Desmond JE, Zhao Z & Gabrieli JD, Sex differences in the neural basis of emotional memories, Proc Nat! Acad Sci, USA, 99: 10789-10794, 2002.
33. Breiter HC, Etcoff NL, Whalen PJ, Kennedy WA, Rauch SL & Buckner RL, Response and habituation of the human amygdale during visual processing of facial expression, Neuron, 17: 987-887, 1996.
34. Canli T, Sivers H, Whitfield SL, Gotlib IH & Gabrieli JD, Amygdala response to happy faces as a function of extraversion, Science, 296: 2191, 2002.
35. Edited by Kandel ER, Schwartz JH & Jessell TM, Principles of Neural Science, third edition, Appleton & Lange, 1991.
36. Fewell GD & Meredith M, Experience facilitates vomeronasal and olfactory influence on Fos. Expression in medial preoptic area during pheromone exposure or mating in male hamsters, Brain Res, 941 ( 1-2): 91-106, 2002.
37. Hagan JJ, Salamone JD, Simpson J, Iversen SD & Morris RGM, Place navigation in rats is impaired by lesions of medial septum and diagonal band but not nucleus basalis magnocellularis, Behav Brain Res, 27: 9-20, 1988.
38. Noonan M, Penque M & Axelrod S, Septal lesions impair rats' morris-test performance bur facilitate left-right response differentiation, Physiology & Behav,60: 895-900, 1996.
39. Zeineh MM, Engel SA, Thompson PM & Bookheimer SY, Dynamics of the hippocampus during encoding and retrieval of face-name pairs, Science, 299:577-580, 2003.
40. Martin PD, Locomotion towards a goal alters the synchronous firing of neurons recorded simultaneously in the subiculum and nucleus accumbens of rats, Behav Brain Res, 124: 19-28, 2001.
41. Hampson RE, Hedberg T & Deadwyler SA, Differential information processing by hippocampal and subicular neurons, Ann NY Acad Sci, 911: 151-165, 2000.
42. Cooper DC, Moore SJ, Staff NP & Spruston N, Psychostimulant-induced plasticity of intrinsic neuronal excitability in ventral subiculum, ] Neuroscience,23(30): 9937-9946, 2003.
43. Glasson EJ, Bower C, Petterson B, de Klerk N, Chaney G & Hallmayer JF, Perinatal factors and the development of autism, Arch Gen Psychiatry, 61(6):618-627, 2004.
44. Zwaigenbaum L, Szarmari P, Jones MB, Bryson SE, MacLean JE, Mahoney WJ, Bartolucci G & Tuff L, Pregnancy and birch complications in autism and libility to the broader autism phenotype, J Am Acad Child Adolesc Psychiatry, 41(5): 572-9' 2002.
45. Glasson EJ, Bower C, Petterson B, de Klerk N, Chaney G & Hallmayer JF, Perinatal factors and the development of autism, Arch Gen Psychiatry, 61(6):618-627, 2004.
46. Neave N, Nagle S & Aggleron JP, Evidence for the involvement of the mammillary bodies and cingulum bundle in allocenrric spatial processing by rats, Eur J Neurosci, 9(5): 941-55, 1997.
47. Conejo NM, Gonzalez-Pardo H, Vallejo G & Arias JL, Involvement of the mammillary bodies in spatial working memory revealed by cytochrome oxidase activity, Brain Res, 1011(1): 107-14, 2004.
48. Autism Society of America, Autism Characteristics, //www.autisminfo.com, 2004.
49. Edelson SM, Lack of attention to physical problems in autism, Center for the Study of Autism, 2004.
50. Frankland PW, Bontempi B, Talton LE, Kaczmarek L & Silva AJ, The involvement of the anterior cingulated cortex in remote contextual fear memory, Science, 304: 881-883, 2004.
51. Carter CS, Borvinick MM & Cohen JD, Rev Neurosci, 10: 49, 1999.
52. Robbins TW, Prog Brain Res, 126: 469, 2000.
53. Suhara T, Okubo Y, Yasuno F, Sudo Y, Inoue M, Ichimiya T, Nakashima Y, Nakayama K, Tanada S, Suzuki K, Halldin C & Parde L, Decreased dopamine D2 receptor binding in the anterior cingulate cortex in schizophrenia, Arch Gen Psychiatry, 59: 25-30, 2002.
54. Laurens KR, Ngan ETC, Bates AT, Kiehl KA & Liddle PF, Rostral anterior cingulate cortex dysfunction during error processing in schizophrenia, Brain, A Journal of Neurology, 126(3): 610-622, 2003.
55. Rosenberg DR, Mirza Y, Russell A, Tang J, Smith JM, Banerjee SP, Bhandari R, Rose M, Ivey J, Boyd C & Moore GJ, Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls, J Am Acad Child Adolesc Psychiatry, 43(9): 1146-1153, 2004.
56. Dept of Psychiatry, Understanding obsessive-compulsive and related disorders, Stanford School of Medicine, 2004.
57. Uher R, Murphy T, Brammer MJ, Dalgleish T, Phillips ML, Ng VW, Andrew CM, Williams SC, Campbell CT & Reasure J, Medial prefrontal cortex activity associated with symptom provocation in eating disorders, Am J Psychiatry, 161:1238-1246, 2004.
58. Filion M, ENDO: Testosterone may help treat anorexia nervosa, Doctor's Guide Publishing Ltd., 2004.
59. Sullivan RC, Definition of Autism, Autism Society of Pittsburgh, 1997.
60. Crescent Life, Autism. //www.crescentlife.com/disorders/ aurism.htm, 2004.
61. American Psychiatric Association: Diagnostic and Statictical Manual of Mental Disorders, fourth Edition. \Washington, DC, American Psychiatric Association, 1994.
62. Lee M, Martin-Ruiz C, Graham A, Court J, Jajors E, Perry R, Iversen P, Bauman M & E, Nicotine receptor abnormalities in the cerebellar cortex in autism, Brain, 1483-1495, 2002.
63. Hashimoto T, Tayama M, Murakawa K, Yoshimoto T, Miyazaki M, Harada M & Kuroda Y, Development of the brainscem and cerebellum in autistic patients, J Autism Dev Disord, 25(1): 1-17, 1995.
64. Piven J, Nehme E, Simon J, Barta P, Pearlson G & Polscein SE, Magnetic resonance in autism: measurement of the cerebellum, pons, and fourth ventricle, Bioi Psychiatry, 31: 491-504, 1992.
65. Edited by Bauman ML & Kemper TL, The neurobiology of autism, John Hopkins University Press, 1994.
66. Courchesne E, Redcay E & Kennedy DP, The autistic brain: birth through adulthood, Curr Opin Neurology, 17: 489-496, 2004.
67. Langleben DD, Schroeder L, Maldjian JA, Gur RC, McDondals S, Ragland JD, O'Brien CP & Childress AR, Brain activity during stimulation deception: an event-related functional magnetic resonance study, Neuroimage, 15: 727-732, 2002.
68. Kozel FA, Padgett TM & George MS, A Replication study of the neural correlates of deception, Behav Neurosci, 118(4): 852-856, 2004.
69. Leekam SR & Prior M, Can autistic children distinguish lies from jokes? A second look at second-order belief attribution, J Child Psycho Psychiatry, 35(5):901-15, 1994.
70. Reinecke DR, Newman B, Kurtz AL, Ryan CS & Hemmes NS, Teaching deception skills in a game-play context to three adolescents with autism, J Autism Dev Disord, 27(2): 127-37, 1997.
71. Grant CM, Grayson A & Boucher J, Using tests of false belief with children with autism: how valid and reliable are they? Autism, 5(2): 135-145, 2001.
72. Grossberg S & Merrill JW, A neural network model of adaptively timed reinforcement learning and hippocampal dynamics, Brain Res Cogn Brain Res,1 (1): 3-38, 1992.
73. Eichenbaum H, Hippocampus: cognitive processes and neural representations that underlie declarative memory, Neuron, 44(1): 109-20, 2004.
74. Aggleton JP, Kyd RJ & Bilkey DK, \1Vhen is the perirhinal cortex necessary for the performance of spatial memory tasks? Neurosci Biobehav Rev, 28(6):611-624, 2004.
75. Buckley CT & Caldwell KK, Fear conditioning is associated with altered integration of PLC and ERK2 signaling in the hippocampus, Pharmacal Biochem Behav, 79(4): 633-40, 2004.
76. Burwell RD, Bucci DJ, Sanborn MR & Jutras MJ, Perirhinal and postrhinal contributions to remote memory for context, J Neurosci, 24(49): 11023-11028, 2004.
77. Kirwan CB, Gilbert PE & Kesner RP, The role of the hippocampus in the retrieval of a spatial location. Neurobiol Learn Mem, 83(1): 65-71, 2005.
78. Kier EL, Kim JH, Fulbright RK & Bronen RA, Embryology of the human feral hippocampus: MR imaging, anatomy, and histology, Am J Neuroradiology, 18(3): 525-532, 1997.
79. Tsien JZ, Huerta PT & Tonegawa S, The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory, Cell, 87:1327-1338, 1996.
80. McHugh TJ, Blum KI, Tsien JZ, Tonegawa S & Wilson MA, Impaired hippocampal representation of space in CAl-specific NMDARl knockout mouse, Cell, 87: 1339-1349, 1996.
81. Rondi-Reig L, Libbey M, Eichenbaum H & Tonegawa S, CAl-specific N merhyl-D-asparrate receptor knockout mice are deficient in solving a nonspatial transverse patterning tasl, PNAS USA, 98: 3543-3548, 2001.
82. Fukaya M, Karo A, Lovett C, Tonegawa T & Watanabe M, Retention of NMDA receptor NR2 subunits in the lumen of endoplasmic reticulum m targeted NRI knockout mice, PNAS USA, 100: 4855-4860, 2003.
83. Shimizu E, Rampon C & Tsien JZ, NMDA receptor-dependent synaptic reinforcement as a crucial process for memory consolidation, Science,290: 1170-1174,2000.
84. Cui Z, Wang H, Tan Y, Zaia KA, Zhang S & Tsien JZ, Inducible and reversible NRI knockout reveals crucial role of the NMDA receptor in preserving remote memories in the brain, Neuron, 41:781-793, 2004.
85. Cesaroni L & Garber M, Exploring the experience of autism through firsthand accounts, J Autism Dev Disord, 21(3): 303-313, 1991.
86. Sparling & Wilhelm, Quantitative measurement of fetal movement: fetal posture and movement assessment. Physical and Occupational Therapy in Pediatrics, 12(2/3): 97-114, 1993.
87. Sparling JW, Van To! J & Chescheir NC, Feral and neonatal hand movement, Phys Ther, 79(1): 24-39, 1999.
88. Cao J, Chen N, Xu T & Xu L, Stress-facilitated LTD induces output plasticity through synchronized-spikes and spontaneous unitary discharges in the CAl region of the hippocampus, Neurosci Res, 49:229-239, 2004.
89. Williams E, Costal A & Reddy V, Children with autism experience problems with both objects and people, J Autism Dev Disord, 29(5): 367-379, 1999.
90. American Psychiatric Association: Diagnostic and Statictical Manual of Mental Disorders, fourth Edition. Washington, DC, American Psychiatric Association, 1994.
91. Edited by Bauman ML & Kemper TL, The neurobiology of autism, John Hopkins University Press, 1994.
92. Ornitz, Lane, Sugiyama & Traversay, Startle response in autism, J Autism Dev Disord, 23(4), 1993.
93. Edited by Bauman ML & Kemper TL, The neurobiology of autism, John Hopkins University Press, 1994.
94. Jakob H & Beckman H, Circumscribed malformation and nerve cell alterations in the entorhinal cortex of schizophrenics, J Neural Transm, 98:83-106, 1994
95. Wood D, Autism, pervasive development disorder I /www.aurorahealthcare.com, 2004.,
96. Kaufman Children's Center, Sign and Symptoms, I /kidspeech.com, 2004.
97. Buckmaster CA, Eichenbaum H, Amaral DG, Suzuki WA & Rapp PR, Entorhinal cortex lesions disrupt the relational organization of memory monkeys, J Neurosci, 24(44}: 9811-9825, 2004.
98. Buchanan TW; Tranel D, Adolphs R, A specific role for the human amygdale in olfactory memory, Learning & Memory, 10: 319-325, 2003.
99. Gould JB, Gluck L & Kulovich MV, The relationship between accelerated pulmonary maturity and accelerate neurological maturity in certain chronically stressed pregnancies, Am] Obstet Gynecol, 127(2): 181-186, 1977.
100. Vitalis T & Parnavelas JG, The role of serotonin in early cortical development, Dev Neurosci, 25: 245-256, 2003.
101. Wu C, Dias P, Kumar S, Lauder JM & Singh S, Differential expression of serotonin 5-HT2 receptors during rat embryogenesis, Dev Neurosci, 21 (1):22-28, 1999.
102. Hevner RF & Kinney HC, Reciprocal entorhinal-hippocampal connections established early in human feral gestation, J Comp Neural, 372: 384--394, 1996.
103. Webb SJ, Monk CS & Nelson CA,. Mechanisms of postnatal neurobiological development: implications for human development, Dev Neuropsychology, 19(2): 147-171, 2001.
104. Brake WG, Zhang1Y, DiorioJ, Meaney MJ & Gratton A, Influence of early postnatal rearing conditions on mesocorticolimbic dopamine and behavioral responses to psychostimulants and stressors in adult rats, Eur] Neurosci, 19(7):1863-1874, 2004.
105. Ziabreva I, Poeggel G, Schnabel R & Braun K, Separation-induced receptor changes in the hippocampus and amygdale of octodon degus: influence of maternal vocalizations, J NeuroSci, 23(12): 5329-5336, 2003.
106. Wigger A & Neumann ID, Periodic maternal deprivation induces gender dependent alterations in behavioral and neuroendocrine responses to emotional stress in adult rats, Physiol Behav, 66(2): 293-302, 1999.
106a. Matthews K, Dalley JW, Matthews C, Tsai TH & Robbins TW; Periodic maternal separation of neonatal rats produces region- and gender-specific effects on biogenic amine content in postmortem adult brain, Wiley InterScience, 40( I):1-10, 2001.
107. Nicolson NA, Childhood parental loss and cortisol levels in adult men, Psychoneuroendocrinology, 29(8): 1012-1018, 2004.
108. Altemus M, Cloitre M & Dhabhar FS, Enhanced cellular immune response in women with PTSD related to childhood abuse, Am J Psychiatry, 160:1705-1707,2003.
109. Goodwin RD & Stein MB, Association between childhood trauma and physical disorders among adults in the United States, Psycho! Med, 34(3):509-520, 2004.
110. Carette S, Suttees PG, Wainwright NW, Khaw KT, Symmons DP & Silman AJ, The role of life events and childhood experiences in the development of rheumatoid arthritis, J Rheumatol, 27(9): 2123-2130, 2000.
111. Kaufman J, Birmaher B, Perel J, Dahl RE, Moreci P, Nelson B, Wells W & Ryan ND, The corticotrophin-releasing hormone challenge in depressed abused, depressed non abused, and normal control children. Bioi Psychiatry, 42(8):669-679, 1997.
112. De Bellis MD, Chrousos GP, Dorn LD, Burke L, Helmers K, Kling ViA, Trickett PK & Putnam FW, Hypothalamic-pituitary-adrenal axis dysregulation in sexually abused girls, J Clin Endocrinol Metab, 78(2): 249-255, 1994.
113. Stein MB, Yehuda R, Koverola C & Hanna C, Enhanced dexamethasone suppression of plasma cortisol in adult women traumatized by childhood sexual abuse, Bioi Psychiatry, 42(8): 680-686, 1997.
114. Heim C, Ehlert U, Hanker JP & Hdlhammer DH, Abuse-related posttraumatic stress disorder and alterations of the hypothalamic-pituitary adrenal axis in women with chronic pelvic pain, Psychosom Med, 60(3): 309-318, 1998.
115. King JA, Mandansky D, King S, Fletcher KE & Brewer J, Early sexual abuse and low cortisol, Psychiatry Clin Neurosci, 55(1): 71-74, 2001.
116. Rinne T, de K.loet ER, Wouters L, Goedkoop JG, De Rijk RH & van den Brink W, Hyperresponsiveness of hypothalamic-pituitary-adrenal axis to combine dexamethasone/corticotrophin-releasing hormone challenge in female borderline personality disorder subjects with a history of sustained childhood abuse, Bioi Psychiatry, 52(11): 1102-1012, 2002.
117. Suttees P, Wainwright N, Day N, Brayne C, Luben R & Khaw KT, Adverse experience in childhood as a developmental risk factor for alter immune status in adulthood, Int J Behav Med, 10(3): 251-268, 2003.
118. Dube SR, Anda RF, Felitti VJ, Chapman DP, Williamson DF & Giles WH, Childhood abuse, household dysfunction, and the risk of attempted suicide throughout the life span: findings from the Adverse Childhood Experiences Study, JA.t\1A, 286(24): 3089-3096, 2001.
119. Rossow I & Lauritzen G, Shattered childhood: a key issue in suicidal behavior among drug addicts, Addiction, 96(2): 227-240, 2001.
120. Levitan RD, Parikh SV, Lesage AD, Hegadoren KM, Adams M, Kennedy SH & Goering PN, Major depression in individuals with a history of childhood physical or sexual abuse: relationship in neurovegetative features, mania, and gender, AmJ Psychiatry, 155(12): 1746-1752,2001.
121. Bandelow B, Spath C, Tichauer GA, Broocks A, Hajak G & Ruther E, Early traumatic life events, parental attitudes, family history, and birth risk factors in patients with panic disorder, Compr Psychiatry, 43(4): 269-278, 2002.
122. Talbot NL, Duberstein PR, Cox C, Denning D, Conwell Y, Preliminary report on childhood sexual abuse, suicidal ideation, and suicide attempts among middle-aged and older depressed women, Am J Psychiatry, 12(5): 536-538,2004.
123. Saleptsi E, Bichescu D, Rockstroh B, Neuner F, Schauer M, Studer K, Hoffmann K & Elbert T, Negative and positive childhood experiences across developmental periods in psychiatric patients with different diagnoses an explorative study, BMC Psychiatry, 4(1): 40, 2004.
124. Bremner JD, Vermenen E, Afzal N & Vythilingam M, Deficits in verbal declarative memory function in women with childhood sexual abuse-related posttraumatic stress disorder, J Nerv Ment Dis, 192(10): 643-649, 2004.
125. Mireault GC & Bond LA, Parental death in childhood: perceived vulnerability, and adult depression and anxiety, Am J Orthopsychiatry, 62(4):517-524, 1992.
126. Kivela SL, Luukinen H, Koski K, Viramo P & Pahkala K, Early loss of mother or father predicts depression in old age, lnt J Geriatr Psychiatry, 13(8):527-530, 1998.
127. Luecken L J, Attachment and loss experiences during childhood are associated with adult hostility, depression, and social support, J Psychosom Res, 49(1): 85-91, 2000.
128. Kanugi H, Sugawara N, Aoki H, Nanko S, Hirose T & Kazamatsuri H, Early parental loss and depressive disorder in Japan, Eur Arch Psychitary Clin Neurosci, 245(2): 109-113, 1995.
129. Furukawa T, Harai H, Hirai T, Fujihara S, Kitamura T & Takahashi K, Childhood parental loss and alcohol dependence among Japanese men: a case control study. Group for Longitudinal Affective Disorders Study (GLADS), Acta Psychiatr Scand, 97(6): 403--407, 1998.
130. Kendler KS, Neale MC, Prescott CA, Kessler RC, Heath AC, Corey LA & Eaves LJ, Childhood parental loss and alcoholism in women: a causal analysis using a twin-family design, Psycho! Med, 26(1): 79-95, 1996.
131. Furukawa TA, Ogura A, Hirai T, Fujihara S, Kitamura T & Takahashi K, Early parental separation experiences among patients with bipolar disorder and major depression: a case-control study, J Affect Disord, 52(1-3): 85-91, 1999.
132. Dindo L & Coryell W, Comorbid major depression and panic disorder: significance of temporal sequencing to familial transmission, J Affect Disord,82(1): 119-123,2004.
133. Dannon P, Sason M, Shalgi B, Tusan L, Sapir Y & Kotler M, Comorbid psychiatric symptoms in pathological gamblers: depression and substance abuse, Harefuah, 143(9): 643-646, 695, 2004.
134. James A, Lai FH & Dahl C, Attention Deficit hyperactivity disorder and suicide: a review of possible associations, Acta Psychiatr Scand, 110(6): 408--415, 2004.
135. Rounsavill BJ, Treatment of cocaine dependence and depression, Bioi Psychiatry, 56(10): 803-809, 2004.
136. Speranza M, Corcos M, Levi G & Jeammet P, Obsessive-compulsive symptoms as a correlate of severity in the clinical presentation of eating disorders: measuring the effects of depression, Eat Weight Disord, 4(3): 121-127, 1999.
137. Serpell L, Livingstone A, Neiderman M & Lask B, Anorexia nervosa: obsessive compulsive disorder, obsessive-compulsive personality disorder, or neither? Clin Psycho Rev, 22(5): 647-669, 2002.
138. Nagata T, Kawarada Y, Ohshima J, Iketani T & Kiriike N, Drug use disorders in Japanese eating disorder patients, Psychiatry Res, 109(2): 181-191,2002.
139. Rudd MD, Dahm PF & Rajab MH, Diagnostic comorbidity in persons with suicidal ideation and behavior, Am J Psychiatry, 150(6): 928-934, 1993.
140. Bizeul C, Brun JM & Rigaud D, Depression influences the EDI scores in anorexia nervosa patients, Eur Psychiatry, 18(3): 119-123, 2003.141. Kaye WH, Bulik CM, Thornton L, Barbarich N & Masters K, Comorbidity of anxiety disorders with anorexia and bulimia nervosa, Am J Psychiatry, 161(12):2215-2221, 2004.
142. Riemann D, Hohagen F, Bahro M & Berger M, Sleep in depression: the influence of age, gender and diagnostic subtype on baseline sleep and the cholinergic REM induction test with RS 86, Eur Arch Psychiatry Clin Neurosci,243: 279-290, 1994.
143. Soldatos CR, Insomnia in relation to depression and anxiety epidemiologic considerations, J Psychosomatic Res, 38(1): 3-8, 1994.
144. Bourdet C & Goldenberg F, Insomnia in anxiety: sleep EEG changes, J Psychosomatic Res, 38(1): 93-104, 1994.
145. Torres AR, Dedomenico AM, Crepaldi AL & Miguel EC, Obsessive-compulsive symptoms in patients with panic disorder, Compr Psychiatry, 45(3):219-224, 2004.
146. Klim YR, Park Q & Yu BH, Changes in lymphocyte subsets after short-term pharmacotherapy in patients with panic disorder, Psychicary Res, 128(2):183-190, 2004.
147. Trifiletti RR & Packard AM, Immune mechanisms in pediatric neuropsychiatric disorders. Tourette's syndrome, OCD, and PANDAS, Child Adolesc Psychiatr Clin N Am, 8(4): 767-775, 1999.
148. Ravindran AV, Griffiths J, Merali Z & Anisman H, Circulating lymphocyte subsets in obsessive compulsive disorder, major depression and normal controls, J Affect Disord, 52(1-3): 1-10, 1999.
149. Monteleone P, Catapano F, Fabrazzo M, Tortorella A & Maj M, Decreased blood levels of tumor necrosis factor-alpha in patients with obsessive-compulsive disorder, Neuropsychobiology, 37(4): 182-185, 1998.
!50. Andreoli AV, Keller SE, Rabaeus M, Marin P, Bartlett JA & Taban C, Depression and immunity: age, severity and clinical course, Brain Behav Immun,7: 279-292, 1993.
151. Bartlett JA, Schleifer SJ, Demetrikopoulos MK & Keller SE, Immune differences in children with and without depression, Bioi Psychiatry, 38:771-774, 1995.
152. Andreoli A, Keller SE, Rabaeus M, Zaugg L, Garrone G & Taban C, Immunity, major depression, and panic disorder comorbidity, Bioi Psychiatry, 31:896-908, 1992.
153. Birmingham CL, Hodgson DM, Fung J, Brown R, Wakefield A, Barttop R& Beumont P, Reduced febrile response to bacterial infection in anorexia nervosa patients, Int J Eat Disord, 34(2): 269-272, 2003.
154. Kahl KG, Hruse N, Rieckmann P & Schmidt MH, Cytokine mRNA expression patterns in the disease course of female adolescents with anorexia nervosa, Psychoneuroendocrinolog, 29(1): 13-20, 2004.
155. NovaE, Gomez-Martinez S, Morande G & Marcos A, Cytokine production by blood mononuclear cells from in-patients with anorexia nervosa, Br J Nutr,88(2): 183-188, 2002.
156. Corcos M, Guilbaud 0, Paterniti S, Moussa M, Chambry J, Chaouat G, Consoli SM & Jeammet P, Involvement of cytokines in eating disorders: a critical rev1ew of the human literature, Psychoneuroendocrinology, 28(3): 229-249,2003.
157. Opdal SH, Opstad A, Vege A & Rognum TO, IL-10 gene polymorphisms are associated with infectious cause of sudden infant death, Hum Immunol,64(12): 1183-1189, 2003.
!58. Gleeson M & Cripps AW, Development of mucosal immunity in the first year of life and relationship to sudden infant death syndrome, FEMS Irnmunol Med Microbial, 42(1): 21-33, 2004.
159. Harrison LM, Morris ]A, Bishop LA, Lauder RM, Taylor CA &Telford DR, Detection of specific antibodies in cord blood, infant and maternal saliva and breast milk to staphylococcal toxins implicated in sudden infant death syndrome (SIDS), FEMS Immunol Med Microbial, 42(1): 94--104, 2004.
160. Prandota J, Possible pathomechanisms of sudden infant death syndrome: key role of chronic hypoxia, infection/inflammation states, cytokine irregularities, and metabolic trauma in genetically predisposed infants, Am J Ther, 11(6): 517-546,2004.
161. Aida M & Hrdina PD, Distribution of platelet 5-HT(2A) receptor densities in suicidal and non-suicidal depressives and control subject, Psychiatry Res, 94(3):273-277, 2000.
162. Mendelson SD, The current status of the platelet 5-HT(2A) receptor in depression, J Affect Disord, 57(1-3): 13-24, 2000.
163. Audenaert K, Van Laere K, Dumont F, Vervaet M, Goethals I, Slegers G, Mertens J, Van Heeringen C & Dierckx RA, Decreased 5-HT(2A) receptor binding in patients with anorexia nervosa,] Nuclear Med, 44(2): 163-169, 2003.
164. Schruers K & Griez E, The effects of rianeptine or paroxetine on 35% C02 provoked panic in panic disorder, J Psychopharmacol, 18(4): 553-558, 2004.
165. Bertani A, Perna G, Migliarese G, DiPasquale D, Cucchi M, Caldirola D & Bellodi L, Comparison of the treatment with paroxetine and reboxetine in panic disorder: a randomized, single-blind study, Pharmacopsychiarry, 37(5): 206-210,2004.
166. Wiegand MH, Galanakis P & Schreiner R, Nefazodone in primary insomnia: an open pilot study, Prog Neuropsychopharmacol Bioi Psychiatry,28(7): 1071-1078, 2004.
167. Mulrow CD, Williams JW Jr, Trivedi M, Chiquette E, Aguilar C, Cornel JE, Badger Noel PH, Lawrence V, Lee S, Luther M, Ramirez G, Richardson WS & Stamm K, Treatment of depression newer pharmacotherapies, Psychopharmacol Bull, 34(4): 409-795, 1998.
168. Corman SL, Fedutes BA & Culley CM, Aromoxetine: the first nonstimulant for the management of attention-deficit/hyperactivity disorder, Am J Health Sysr Pharm, 61(22): 2391-2399, 2004.
169.0quendo MA, Kamali M, Ellis SP, Grunebaum MF, Malone KM, Brodsky BS, Sackeir HA & Mann JJ, Adequacy of antidepressant treatment after discharge and the occurrence of suicidal acts in major depression: a prospective study, Am J Psychiatry, 159(10): 1746-1751,2002.
170. Sweet RA, Bergen SE, Sun Z, Sampson AR, Pierri JN & Lewis DA, Pyramidal cell size reduction in schizophrenia: evidence for involvement of auditory feedforward circuits, Bioi Psychiatry, 55: 1128-1137, 2004.
171. Goldstein JM, Goodman JM, Seidman LJ, Kennedy DN, Makris N & Lee H, Cortical abnormalities in schizophrenia identified by structural magnetic resonance imaging, Arch Gen Psychiatry, 56: 537-547, 1999.
172. Hirayasu Y, Shenton ME, Salisbury DF, Dickey CC, Fischer IA & Mazzoni P, Lower left temporal lobe MRI volumes in patients with first-episode schizophrenia compared with psychotic patients with first-episode affective disorder and normal subjects, Am J Psychiatry, 155: 1384-1391, 1998.
173. Shergill SS, Brammer MJ, Amaro E, Williams SC, Murray Rivi & McGuire PK, Temporal course of auditory hallucinations, Br] Psychiatry, 185: 516-517, 2004.
174. Hayashi N, Igarashi Y, Suda K & Nakagawa S, Phenomenological features of auditory hallucinations and their symptomalological relevance, Psychiatry Clin Neurosci, 58(6): 651-659, 2004.
175. Dahmen N, Kasten M, Mittag K & Muller MJ, Narcoleptic and schizophrenic hallucinations Implications for differential diagnosis and pathophysiology, Eur J Health Econ, 3 Suppl 2: s94-98, 2002.
176. Martin JA & Penn DL, Attriburional in schizophrenia: an investigation in outpatients with and without persecutory delusions, Schizophr Bull, 28(1):131-141,2002.
177. Allen PP, Johns LC, Fu CH, Broome MR, Vythelingum GN & McGuire PK, Misattribution of external in patients with hallucinations and delusions, Schizophr Res, 69(2-3): 277-287, 2004.
178. Forte FS, Olfactory hallucinations as a procrologic manifestation of early schizophrenia, Am J Surg, 84(5): 620-622, 1952.
179. MedTerms, Hallucination, 1/wwvr.MedicineNet.com, 2005.
180. American Psychiatric Association: Diagnostic and Statictical Manual of Mental Disorders, fourth Edition, Washington, DC, American Psychiatric Association , 1994.
181. Hansson LO, Waters N, Winblad B, Gotrfries CG & Carlsson A, Evidence for biochemical heterogeneity in schizophrenia: a multivariate study of monoaminergic indices in human post-mortal brain tissue, J Neural Transm, 98:217-235, 1994.
182. Jones HM & Pilowsky LS, Dopamine and antipsychotic drug action revisited, British J Psychiatry, 181: 271-275, 2002.
183. Jollier P & Bourin M, Pharmacology of new antipsychotic drugs: Are they stabilizers of schizophrenic psychosis? Drugs News Perspect, 11(10): 625-630,1998.
184. Llorca PM & Pere JJ, Clozapine, 10 years after - A clinical review, Encephale, 30(1): 474-491, 2004
185. Bai J, He F, Novikova SI, Undie AS, Dracheva S, Harouyunian V & Lidow MS, Abnormalities in the dopamine system in schizophrenia may lie in altered levels of dopamine receptor-interacting proteins, Bioi Psychiatry, 56(6): 427-440,2004.
186. Jeong SH, Joo EJ, Ahn YM & Kim YS, Association study of dopamine transporter gene and schizophrenia in Korean population using multiple single nucleotide polymorphism markers, Prog Neuropsychopharmacol Bioi Psychiatry, 28(6): 975-983, 2004.
187. Lawford BR, Young RM, Swagell CD, Barnes M, Burton SC, Ward WK, Heslop KR, Shadforth S, van Daal A & Morris CP, The C/C genotype of the C957T polymorphism of the dopamine D2 receptor is associated with schizophrenia, Schizophr Res, 73(1): 31-37, 2005.
188. Goldman-Rakic PS, Castner SA, Svensson TH, Siever LJ & Williams GV, Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction, Psychopharmacology, 174(1): 3-16, 2004.
189. Bergson C, Levenson R, Goldman-Rakic PS & Lidow MS, Dopamine receptor-interacting proteins: the Ca (2+) connection in dopamine signaling, Trends Pharmacal Sci, 24(9): 486-492, 2003.
190. American Psychiatric Association: Diagnostic and Statictical Manual of Mental Disorders, fourth Edition. Washington, DC, American Psychiatric Association, 1994.
191. Bellino S, Rocca P, Patria L, Marchiaro L, Rasetti R, DiLorenzo R, Paradiso E & Bogetti F, Relationships of age at onset with clinical features and cognitive functions in a sample of schizophrenia patients, J Clin Psychiatry, 65(7):908-914, 2004.
192. Hafner H, Maurer K, Loffier W & Riecher-Rossler, The influence of age and sex on the onset and early course of schizophrenia, Brit J Psychiatry, 162: 80-86,1993.
193. Schizophrenia Fellowship, Late Life. //www.sfnsm.org.au, 2005.
194. Goff DC & Evins AE, Negative symptoms in schizophrenia: neurobiological models and treatment response, Har Rev Psychiatry, 6(2): 59-77, 1998.
195. Malia AK, Takhar JJ, Norman RM, Manchanda R, Cortese L, Haricharan R, Verdi M & Ahmed R, Negative symptoms in first episode non-affective psychosis, Acta Psychiarr Scand, 105(6): 431-439,2002.
196. Bogens B, Zur Neuropathologic der Schizophrenien, Fortschr Neurol Psychiat, 52: 428-437, 1984.
197. Bogerts B, Schizophrenien als Erkrankungen des limbischen Systems. In Huber G ed., Basisstadien endogener Psychosen und das Borderline4Problem, Stuttgart: Schattauer: 163-179, 1985.
198. Bogerts B, David S, Falkai P & Tapernion-Franz U, Quantitative evaluation of astrocyte densities in schizophrenia, Presented at the 17th Congress of the Collegium Internationale Neuro-Psychopharmacologicum, Kyoto: Abst P-13l-122, 1990.
199. Colter N, Battal S, Crow TJ, Johnstone EC, Brown R & Bruton CI, White matter reduction in the parahippocampal gyrus of patients with schizophrenia, Arch Gen Psychiat, 44: 1023, 1987.
200. Gur RC, Schroeder L, Turner T, McGrath C, Chan lUvl, Turetsky BI, Alsop 0, Maldji J & Gur RE, Brain activation during facial emotion processing, Neuroimage, 16(3 Pt 1): 651-662, 2002.
201. Phillips ML, Young AW, Scott SK, Calde AJ, Andrew C, Giampietro V, Williams SC, Bullmore ET, Brammer M & Gray JA, Neural responses to facial and vocal expressions of fear and disgust, Proc R Soc Lond B Bioi Sci, 265(1408):1809-1817, 1998.
202. Phelps EA, O'Connor KJ, Gatenby JC, Gore JC, Grillon C & Davis M, Activation of the left amygdale to a cognitive representation of fear, Nat Neurosci,4(4): 437-441, 2001.
203. Schneider F, Weiss U, Kessler C, Salloum JB, Posse S, Grodd W, Muller Gannet HW, Differential amygdale activation in schizophrenia during sadness, Schizophr Res, 34(3): 133-142, 1998.
204. Phillips ML, Williams L, Senior C., Bullmore ET, Brammer MJ, Andrew C, Williams SC & David AS, A differential neural response to threatening and non threatening negative facial expressions in paranoid and non-paranoid schizophrenics, Psychiatry Res, 92(1): 11-31, 1999.
205. Kucharska-Pietura K, Russell T & Masiak M, Perception of negative affect in schizophrenia - functional and structural changes in the amygdale. Review, Ann Univ Mariae Curie Sklodowska, 58(2): 453-458, 2003.
206. Jayakumar PN, Gangadhar BN, Subbakrishna OK, Janakiramaiah N, Srinivas JS & Keshavan MS, Membrane phospholipids abnormalities of basal ganglia in never-treated schizophrenia: a 31 P magnetic resonance spectroscopy study, Bioi Psychiatry, 54(4): 491-494, 2003.
207. Bogerts B, Meertz E & Schonfeldt-Bausch R, Basal ganglia and limbic system pathology in schizophrenia. A morphometric study of brain volume and shrinkage, Arch Gen Psychiatry, 42(8): 784-791, 1985.
208. Gangadhar BN, Jayakumar PN, Subbakrishna DK, Janakiramaiah N & Keshavan MS, Basal ganglia high-energy phosphate metabolism in neuroleptic naive patients with schizophrenia: a 31-phosphorus magnetic resonance spectroscopic Am] Psychiatry, 161(7): 1304-1306, 1985.
209. Buckley P, O'Callaghan E, Mulvany F, Larkin C, Stack JP, Redmond 0, Ennis JT, Thompson P & Waddington JL, Basal T2 relaxation times in schizophrenia: a quantitative magnetic resonance imaging study in relation to tardive dyskinesia, Psychiatry Res, 61(2): 95-102, 1995.
210. Dassa D, Sham PC, van Os J, Abel K, Jones P & Murray RM, Relationship of birth season to clinical features, family history, and obstetric complication in schizophrenia, Psychiatry Res, 64(1): 11-17, 1996.
211. Matsumoto H, Takei N, Saito F, Kachi K & Mori N, The association between obstetric complications and childhood-onset schizophrenia: a replication study, Psycho Med, 31(5): 907-914, 2001.
212. PretiA, Cardascia L, Zen T, Marchetti M., Favaretto G & Miorto P, Risk for obstetric complications and schizophrenia, Psychiatry Res, 96(2): 127-139,2000.
213. Kirov G, Jones PB, Harvey I, Lewis SW, Toone BK, Rifkin L, Sham P & Murray RM, Do obstetric complications cause the earlier age at onset in male than female schizophrenics? Schizophr Res, 20(1-2): 117-124, 1996.
214. Kodicka-Anrczak M, Gmitrowicz A, Sobow TM & Rabe-Jablonska J, Obstetric complications and Apgar score in schizophrenic patients with prominent positive and prominent negative symptoms, J Psychiatr Res,35(4): 249-257, 2001.
215. Rao ML & Moller HJ, Biochemical findings of negative symptoms in schizophrenia and their putative relevance to pharmacologic treatment, Neuropsychobiology, 30: 160-172, 1994.
216. Sandman CA, Glynn L, Wadhwa PD, Chicz-DeMet A, Porto M & Garite T, Maternal hypothalamic-pituitary-adrenal dysregulation during the third trimester influences human fetal responses, Dev Neurosci, 25: 41-49, 2003.
217. Brown AS & Susser ES, In utero infection and adult schizophrenia, Ment Retard Dev Disabil Res Rev, 8(1): 51-57, 2002.
218. Izumoto Y, Inoue S & Yasuda N, Schizophrenia and the influenza epidemics of 1957 in Japan, Bioi Psychiatry, 46(1): 119-124, 1999.
219. Limosin F, Rouillon F, Payan C, Cohen JM & Strub N, Prenatal exposure to influenza as a risk factor for adult schizophrenia, Acta Psychiatr Scand, I 07(5):331-335, 2003.
220. Wright P, Takei N, Riflcin L & Murray RM, Maternal influenza, obstetric complications, and schizophrenia, Am J Psychiatry, 152(12): 1714-1720, 1995.
221. Brown AS, Begg MD, Gravenstein S, Schaefer CA, Wyatt RJ, Bresnahan M, Babulas V & Susser ES, Serologic evidence of prenatal influenza in the etiology of schizophrenia, Arch Gen Psychiatry, 61(8): 774-780, 2004.
222. Gillmore JH, Jarskog LF, Vadlamudi S & Lauder JM, Prenatal infection and risk for schizophrenia: IL-l?, IL-6 and TNFx inhibit cortical neuron dendrite development, Neuropsychopharmacology, 29: 1221-1229, 2004.
223. Deidman LJ, Talbot NL, Kalinowski AG, McCarley RW, Faraone SV, Kremen WS, Pepple JR & Tsuang MT, Neuropsychological probes of fronto limbic system dysfunction in schizophrenia, Schizophr Res, 6: 55-65, 1992.
224. Kopala L, Good K, Martzke J & Hurwitz T, Olfactory deficits in schizophrenia are not a function of task complexity, Schizophr Res, 17: 195-199,1995.
225. Turetsky BI, Moberg PJ, Roalf DR, Arnold SE & Gur RE, Decrements in volume of anterior ventromedial temporal lobe and olfactory dysfunction in schizophrenia, Arch Gen Psychiatry, 60(12): 1193-1200, 2003.
226. Shergill SS, Brammer MJ, Amaro E, Williams SC, Murray RM & McGuire PK, Temporal course of auditory hallucinations, Br J Psychiatry, 185: 516-517,2004.
227. Onitsuka T, Shenton ME, Salisbury DF, Dickey CC, Kasai K, Toner SK, Frumin M, Kilcinis R, Jolesz FA & McCarley RW, Middle and inferior temporal gyrus gray matter volume abnormalities in chronic schizophrenia: an MRI study, Am J Psychiatry, 161: 1603-1611, 2004.
228. Harrison PJ, Freemantle N & Geddes JR, Meta-analysis of brain weight in schizophrenia, Schizophr Res, 64(1): 25-34, 2003.
229. Flashman LA, McAllister Tw, Andreasen NC & Saylcin AJ, Smaller brain size associated with unawareness of illness in patients with schizophrenia, Am J Psychiatry, 157(7): 1167-1169, 2000.
230. Ward KE, Friedman L, Wise A & Schulz SC, Meta-analysis of brain and cranial size in schizophrenia, Schizophr Res, 22(3): 197-213, 1996.
231. de Witte M, Working memory deficits in schizophrenia and the role of neuroticism, RuG, School of Behav and Cogn NeuroSci, 2004.
232. Talamini LM, Mee
ter M, Elvevaag B, Goldberg TE & Mune J, A computational approach to memory deficit, Neuromod.org/ publications, 2000. 233. Pantelis C, Stuart GW, Nelson HE, Robbins TW & Barnes TR, Spatial working memory deficits in schizophrenia: relationship with tardive dyskinesia and negative symptoms, Am J Psychiatry, 158(8): 1276-1285, 2001.
234. Turner R. & Schiavetto A, The cerebellum in schizophrenia: a case of intermittent ataxia and psychosis-clinical, cognitive and neuroanatomical correlates, J Clin Neurosci, 16(4): 400--408, 2004.
235. Martin P & Albers M, Cerebellum and Schizophrenia: a selective review, Schizophr Bull, 21(2): 241-250, 1995.
236. Kleine JF, Guan Y, Kipiani E, Glonti M, Hoshi M & Buttner U, Trunk position influences vestibular responses of fastigial nucleus neurons in rhea alert monkey, J Neurophysiol, 91: 2090-2100, 2004.
237. Wang CS, YK, Chen M, Chiu NT, Yeh TL & Lee IH, Negative symptoms and regional cerebral blood flow in patients with schizophrenia: a single photon emission computed tomography Kaohsiung J Med Sci,19(9): 464--469, 2003.
238. Potkin SG, Alva G, Fleming K, Anand R, Keator D, Carreon D, Doo M, Jin Y, Wu JC & Fallon JH, A PET study of the pathophysiology of negative symptoms in schizophrenia, Am J Psychiatry, 159: 227-237, 2002.
239. Joseph AB, Anderson WH, O'Leary DH, Brainstem and vermis atrophy in catatonia, Am J Psychiatry, 142(3): 352-354, 1985.
240. Kinney DK, Yurgelun-Todd DA & Woods BT, Neurologic signs in patients with paranoid and nonparanoid schizophrenia, J Neuropsychiatry Clin Neurosci,4: 447--449, 1992.
241. Flashman LA, Flaum M, Gupta S, Andreasen NC, Soft signs and neuropsychological performance in schizophrenia, Am J Psychiatry, 153:526-532, 1996.
242. Dazzan P, Morgan KD, Orr KG, Hutchinson G, Chitnis X, Suckling J, Fearon P, Salvo J, McGuire PK, Mallett RM, Jones PB, Leff J & Murray RM, The structural brain correlates of neurological soft in AESOP first-episode psychoses study, Brain, 127(1): 143-153, 2004.
A-1. Lee M, Martin-Ruiz C, Graham A, Court J, Jaros E, Perry R, Iversen P, Bauman M & Perry E, Nicotine receptor abnormalities in the cerebellar cortex in autism, Brain, 125(Pt7): 1483-1495, 2002.
A-2. Deursch Sl & Campbell M, Status of cholinesterase activities in blood in neuropsychiatric disorders, Neurochem Res, 9(7): 863-869, 1984.
A-3. Chez MG, Aimonovitch M, Buchanan T, Mrazek S & Tremb RJ, Treating autistic spectrum disorders in children: utility of the cholinesterase inhibitor rivastigmine tartrate, J Child Neural, 19(3): 165-169, 2004.
A-4. Perry EK, Lee MLW, Martin-Ruiz CM, Court JA, Volsen SG, Merrit J, Folly E, Iversen PE, Bauman ML, Perry RH & Wenk GL, Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain, Am J Psychiatry,158: 1058-1010, 200 I.
A-5. Miyazaki K, Narita N, Sakuta R, Miyahara T, Naruse H, Okada N & Narita M, Serum neurotrophin concentrations in autism and mental retardation: a pilot srudy, Brain Dev, 26(5): 292-295, 2004.
A-6. Perry R & Perry E, The cholinergic system m Alzheimer's disease, m biochemistry of dementia, John Wiley & Sons, pp 135-183, 1980.
A-7. Nelson KB, Grether JK, Croen LA, Dambrosia JM, Dickens BF, Hansen RL
& Phillips TM, Neuropeptides and neurotrophins in neonatal blood of children with autism, mental retardation, or cerebral palsy, Neurology, 54(3): A247, 2000. A-8. Crawford MA, Doyle W, Leaf A, Leighfield M, Ghebremeskel K & Phylactos A, Nutrition and neurodevelopmental disorders, Nutr Health, 9:81-97, 1993.
A-9. Paumen M, Ishida Y, Muramatsu M, Yamamoto M & Honjo T, Inhibition of carnitine palmitoyltransferasel augments sphingolipid synthesis and palmitate induced apoptosis, J Bioi Chern, 272: 3324-3329, 1997.
A-10. Craciunescu CN, Brown EC, Mar MH, Albright CD, Nadeau MR & Zeisel SH, Folic Acid deficiency during late gestation decreases progenitor cell proliferation and increases apoptosis in fetal mouse brain, J Nutr, 134: 162-166,2004.
A-11. Loy R, Heyer D, Williams CL & Meek WH, Choline-induced spatial memory facilitation correlates with altered distribution and morphology of septal neurons, Adv Exp Med Bioi, 295: 373-382, 1991.
A-12. Meek W & Williams C, Perinatal choline supplementation increases the threshold for chunking in spatial memory, Neuroreport, 8: 3053-3059, 1997.
A-13. Fast D & Vance 0, Nascent VLDL phospholipids composition is altered when phosphatidylcholine biosynthesis is inhibited: Evidence for a novel mechanism that regulates VLDL secretion, Biochim Biophys Acta, 1258:159-168, 1995.
A-14. Cermak JM, Holler T, Jackson DA & Blusztajn JK, Prenatal availability of choline modifies development of the hippocampal cholinergic system, FASEB,12: 349-357, 1998.
A-15. Williams CL, Meek WH, Heyer DO & Loy R, Hypertrophy of basal forebrain neurons and enhanced visuospatial memory in perinatally choline-supplemented rats, Brain Res, 794(2): 225-238, 1998.
A-16. Edited by Bauman ML & Kemper TL, The neurobiology of autism, John Hopkins University Press, 1994.
A-17. Albright CD, Tsai AY, Friedrich CB, Mar MH & Zeisel SH, Choline availability alters embryonic development of the hippocampus and septum in the rat, Brain Res Dev Brain Res, 113(1-2): 13-20, 1999.
A-18. Mellott TJ, Williams CJ, Meek WH & Blusztajn JK, Prenatal choline supplementation advances hippocampal development and enhances MAPK and CREB activation, FASEB, 18(3): 545-547, 2004.
A-19. Li Q, Guo-Ross S, Lewis DV, Turner D, White AM, Wilson WA & Swartzwelder HS, Dietary prenatal choline supplementation alters postnatal hippocampal structure and function, J Neurophysiol, 91(4): 1545-1555,2004.
A-20. Meek WH & Williams CL, Choline supplementation during prenatal development reduces proactive interference in spatial memory, Brain Res Dev Brain, 118(1-2): 51-59, 1999.
A-21. Meek WH, Smith RA & Williams CL, Pre- and postnatal choline supplementation produces long-term facilitation of spatial memory, Dev Psychobiol, 21(4): 339-353, 1988.
A-22. Meek WH & Williams CL, Characterization of the facilitative effects of perinatal choline supplementation on timing and temporal memory, Neuroreport, 8(13): 2831-2835, 1997.
A-23. U.S. Food and Drug Administration, Folic acid fortification, FDA/CFSAN Folic Acid Fact Sheet, February 29, 1996.
A-24. California Department of Developmental Services, DDS Autism Report,2003.
A-25. Wilson CA & Hanin I, Brain-derived neurotrophic factor induced stimulation of septal choline acetyltransferase activity in ethylcholine mustard aziridinium treated rats, Neurosci Lett, 229(3): 149-152, 1997.
A-26. Morse JK, Wiegand SJ, Anderson K, You Y, Caine, Carnahan J, Miller J, DiStefano P, Altar CA & Lindsay RM, Brain-derived neurotrophic factor (BDNF) prevents the degeneration of medial septal cholinergic neurons following fimbria transaction, J Neurosci, 13(10): 4146--4156, 1993.
A-27. Gottschalk W, Pozzo-Miller LD, Figurov A & Lu B, Presynaptic modulation of synaptic transmission and plasticity by brain-derived neurotrophic factor in the developing hippocampus, J Neurosci, 18(17): 6830-6839, 1998.
A-28. Antony AC & Hansen DK, Hypothesis: folate-responsive neural tube defects and neurocristopathies, Teratology, 62(1): 42-50, 2000.
A-29. Daniel JM & Dohanich GP, Acetylcholine mediates the estrogens induced increase in NMDA receptor binding in CAl of the hippocampus and the associated improvement in working memory, J Neurosci, 21(17): 6949-6956,2001.
A-30. Mooney SB, Giudice LC, Endocrinology of pregnancy, Endotext.com,2002.
A-31. Holmes A, Metal-metabolism and autism, //w\vw.audsminfo.com/AmyHolmesMD.htm, 2005.
A-32. Moon Dragon's Health & Wellness, Copper//www.moondragon.org/health/disorders/coppertox.h tml, 2005.
A-33. Armitage A, RoffWarg HP, Rush AJ, Calhoun JS, Purdy DG & Giles DE, Digital period analysis of sleep EEG in depression, Bioi Psychiatry, 31: 52-68,1992.
A-34. Leopola U, Koponen H & Leinonen E, Sleep m panic disorders, J Psychosomatic Res, 18(1): 105-111, 1994.
A-35. Brake WG, Alves SE, Dunlop JC, Lee SJ, Bulloch K, Allen PB, P & McEwen BS, Novel target sites for estrogen action in the dorsal hippocampus: an examination of synaptic proteins, Endocrinology, 142(3):1284-1289, 2001.